Study Evaluating Anxiety and Depression in Patients With Psoriatic Arthritis

This is an epidemiological non-interventional study assessing the prevalence of anxiety and/or depression disorders in patients suffering from Psoriatic Arthritis (PsA) in Spain.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Psoriatic Arthritis Anxiety Disorders Arthritis Arthritis, Psoriatic Bone Diseases Joint Diseases Mental Disorders Musculoskeletal Diseases Psoriasis Skin Diseases Skin Diseases, Papulosquamous Skin and Connective Tissue Diseases Spinal Diseases Spondylarthritis Spondylarthropathies Spondylitis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Reus, Tarragona, 43201, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients both genders over 18 years old
Patients with PsA diagnosis

Exclusion criteria

Patients with PsA that suffer from other rheumatologic diseases or non-concomitant rheumatologic diseases that the investigator considers not to be appropriate for the study.
Patients with any medical or physical condition (cognitive damage or difficulties for understanding) that create difficulties for reading and completing the questionnaires described in the protocol.
Patients that in the study period are taking part in another clinical trial.

Treatment and study plan

Primary outcomes

Prevalence of anxiety and/or depression disorders in patients suffering from PsA in Spain as measured by the Hospital Anxiety and Depression Scale (HAD)

Time frame: 12 months

Secondary outcomes

To assess the relation between the PsA severity and the presence of anxiety and/or depression disorders in patients suffering from PsA in Spain.

Time frame: 12 months

Sponsors and collaborators

Lead sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

Industry

Registry information

Official study title

Anxiety and Depression in Patients With Psoriatic Arthritis: Prevalence and Characteristics

Important dates

Study start: 2008
Primary completion: 2008
Study completion: 2008
First posted: Apr 20, 2009
Registry last updated: May 27, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed